{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T06:56:56Z","timestamp":1763017016764},"reference-count":21,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2010,7,1]],"date-time":"2010-07-01T00:00:00Z","timestamp":1277942400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["General Hospital Psychiatry"],"published-print":{"date-parts":[[2010,7]]},"DOI":"10.1016\/j.genhosppsych.2010.02.001","type":"journal-article","created":{"date-parts":[[2010,4,3]],"date-time":"2010-04-03T08:33:34Z","timestamp":1270283614000},"page":"426-432","source":"Crossref","is-referenced-by-count":16,"title":["Utility of the Beck Depression Inventory to screen for and track depression in injection drug users seeking hepatitis C treatment"],"prefix":"10.1016","volume":"32","author":[{"given":"Paul E.","family":"Holtzheimer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jason","family":"Veitengruber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chia C.","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meighan","family":"Krows","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hanne","family":"Thiede","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Wald","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Roy-Byrne","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.genhosppsych.2010.02.001_bib1","series-title":"National Center for HIV\/AIDS, Viral Hepatitis, STD, and TB Prevention: 2006 Disease Profile","first-page":"17","author":"Centers for Disease Control and Prevention","year":"2008"},{"key":"10.1016\/j.genhosppsych.2010.02.001_bib2","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1002\/hep.510310332","article-title":"The past incidence of hepatitis C virus infection: implications for the future burden of chronic liver disease in the United States","volume":"31","author":"Armstrong","year":"2000","journal-title":"Hepatology"},{"key":"10.1016\/j.genhosppsych.2010.02.001_bib3","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1097\/01.mcg.0000210099.36500.fe","article-title":"Interferon-induced depression in chronic hepatitis C: a review of its prevalence, risk factors, biology, and treatment approaches","volume":"40","author":"Asnis","year":"2006","journal-title":"J Clin Gastroenterol"},{"key":"10.1016\/j.genhosppsych.2010.02.001_bib4","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1056\/NEJMoa011232","article-title":"Treatment of acute hepatitis C with interferon alfa-2b","volume":"345","author":"Jaeckel","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.genhosppsych.2010.02.001_bib5","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1002\/hep.21197","article-title":"Duration of peginterferon therapy in acute hepatitis C: a randomized trial","volume":"43","author":"Kamal","year":"2006","journal-title":"Hepatology"},{"key":"10.1016\/j.genhosppsych.2010.02.001_bib6","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1002\/hep.21043","article-title":"Early monotherapy with pegylated interferon alpha-2b for acute hepatitis C infection: the HEP-NET acute-HCV-II study","volume":"43","author":"Wiegand","year":"2006","journal-title":"Hepatology"},{"key":"10.1016\/j.genhosppsych.2010.02.001_bib7","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1086\/499951","article-title":"Eligibility for treatment of hepatitis C virus infection among young injection drug users in 3 US cities","volume":"42","author":"Hagan","year":"2006","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.genhosppsych.2010.02.001_bib8","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1056\/NEJMoa020047","article-title":"Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection","volume":"347","author":"Fried","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.genhosppsych.2010.02.001_bib9","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1016\/S0140-6736(01)06102-5","article-title":"Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial","volume":"358","author":"Manns","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.genhosppsych.2010.02.001_bib10","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1177\/070674370505000903","article-title":"Comorbid depression among untreated illicit opiate users: results from a multisite Canadian study","volume":"50","author":"Wild","year":"2005","journal-title":"Can J Psychiatry"},{"key":"10.1016\/j.genhosppsych.2010.02.001_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.jad.2007.01.007","article-title":"A randomized trial of paroxetine to prevent interferon-alpha-induced depression in patients with hepatitis C","author":"Morasco","year":"2007","journal-title":"J Affect Disord"},{"key":"10.1016\/j.genhosppsych.2010.02.001_bib12","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1056\/NEJM200103293441303","article-title":"Paroxetine for the prevention of depression induced by high-dose interferon alfa","volume":"344","author":"Musselman","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.genhosppsych.2010.02.001_bib13","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1007\/s001270050088","article-title":"Differential patterns of mental disorders among the homeless in Madrid (Spain) and Los Angeles (USA)","volume":"33","author":"Munoz","year":"1998","journal-title":"Soc Psychiatry Psychiatr Epidemiol"},{"key":"10.1016\/j.genhosppsych.2010.02.001_bib14","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.4088\/JCP.v65n0804","article-title":"Major depressive disorder and borderline personality disorder revisited: longitudinal interactions","volume":"65","author":"Gunderson","year":"2004","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.genhosppsych.2010.02.001_bib15","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1001\/archpsyc.1961.01710120031004","article-title":"An inventory for measuring depression","volume":"4","author":"Beck","year":"1961","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.genhosppsych.2010.02.001_bib16","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1176\/appi.ajp.157.6.867","article-title":"Neuropsychiatric symptoms associated with hepatitis C and interferon alpha: A review","volume":"157","author":"Dieperink","year":"2000","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.genhosppsych.2010.02.001_bib17","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.jad.2006.10.020","article-title":"Reliability and validity of the Hospital Anxiety and Depression Scale and the Beck Depression Inventory (Full and FastScreen scales) in detecting depression in persons with hepatitis C","volume":"100","author":"Golden","year":"2007","journal-title":"J Affect Disord"},{"key":"10.1016\/j.genhosppsych.2010.02.001_bib18","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1176\/appi.psy.44.2.104","article-title":"A prospective study of neuropsychiatric symptoms associated with interferon-alpha-2b and ribavirin therapy for patients with chronic hepatitis C","volume":"44","author":"Dieperink","year":"2003","journal-title":"Psychosomatics"},{"issue":"Suppl 1","key":"10.1016\/j.genhosppsych.2010.02.001_bib19","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.1016\/j.drugalcdep.2007.05.007","article-title":"Methods to recruit and retain a cohort of young-adult injection drug users for the Third Collaborative Injection Drug Users Study\/Drug Users Intervention Trial (CIDUS III\/DUIT)","volume":"91","author":"Garfein","year":"2007","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.genhosppsych.2010.02.001_bib20","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.1097\/QAD.0b013e32823f9066","article-title":"A peer-education intervention to reduce injection risk behaviors for HIV and hepatitis C virus infection in young injection drug users","volume":"21","author":"Garfein","year":"2007","journal-title":"AIDS"},{"issue":"Suppl 20","key":"10.1016\/j.genhosppsych.2010.02.001_bib21","first-page":"22","article-title":"The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10","volume":"59","author":"Sheehan","year":"1998","journal-title":"J Clin Psychiatry"}],"container-title":["General Hospital Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163834310000174?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163834310000174?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,27]],"date-time":"2019-05-27T23:26:50Z","timestamp":1558999610000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0163834310000174"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,7]]},"references-count":21,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2010,7]]}},"alternative-id":["S0163834310000174"],"URL":"https:\/\/doi.org\/10.1016\/j.genhosppsych.2010.02.001","relation":{},"ISSN":["0163-8343"],"issn-type":[{"value":"0163-8343","type":"print"}],"subject":[],"published":{"date-parts":[[2010,7]]}}}